Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wesnes

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
European Journal of Clinical Pharmacology|January 1, 1995
The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjectsW M O'Neill, G W Hanks, L White, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoinW G Rapeport, D C Muirhead, S A Williams, et al.
Behavioural Brain Research|January 26, 2020
Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60-75 years?M T Fard, L Cribb, K Nolidin, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2000
Cognitive performance in hypertensive and normotensive older subjectsF Harrington, B K Saxby, I G McKeith, et al.
Respiratory Medicine|August 16, 2006
Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndromeM Hirshkowitz, J E Black, K Wesnes, et al.
Human Psychopharmacology|May 10, 2007
An open-label study of quetiapine in anorexia nervosaP Bosanac, S Kurlender, T Norman, et al.
International Journal of Geriatric Psychiatry|September 30, 2017
Online assessment of risk factors for dementia and cognitive function in healthy adultsJ Huntley, A Corbett, K Wesnes, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Moxonidine and cognitive function: interactions with moclobemide and lorazepamK Wesnes, P M Simpson, B Jansson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1992
Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive functionJ van Harten, L A Stevens, M Raghoebar, et al.
Psycho-Oncology|February 6, 1998
The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trialL G Walker, M B Walker, S D Heys, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Clinical Pharmacology|January 1, 1995
The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjectsW M O'Neill, G W Hanks, L White, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Absence of effect of sertraline on the pharmacokinetics and pharmacodynamics of phenytoinW G Rapeport, D C Muirhead, S A Williams, et al.
Behavioural Brain Research|January 26, 2020
Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60-75 years?M T Fard, L Cribb, K Nolidin, et al.
Hypertension (Dallas, Tex. : 1979)|January 11, 2000
Cognitive performance in hypertensive and normotensive older subjectsF Harrington, B K Saxby, I G McKeith, et al.
Respiratory Medicine|August 16, 2006
Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndromeM Hirshkowitz, J E Black, K Wesnes, et al.
Human Psychopharmacology|May 10, 2007
An open-label study of quetiapine in anorexia nervosaP Bosanac, S Kurlender, T Norman, et al.
International Journal of Geriatric Psychiatry|September 30, 2017
Online assessment of risk factors for dementia and cognitive function in healthy adultsJ Huntley, A Corbett, K Wesnes, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Moxonidine and cognitive function: interactions with moclobemide and lorazepamK Wesnes, P M Simpson, B Jansson, et al.
Clinical Pharmacology and Therapeutics|October 1, 1992
Fluvoxamine does not interact with alcohol or potentiate alcohol-related impairment of cognitive functionJ van Harten, L A Stevens, M Raghoebar, et al.
Psycho-Oncology|February 6, 1998
The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trialL G Walker, M B Walker, S D Heys, et al.
Pageof 7